The limits of responsible innovation: Exploring care, vulnerability and precision medicine

Anne Kerr, Rosemary Lucy Hill, Christopher Till

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Drawing on insights from feminist and Science and Technology Studies writing on care and vulnerability, this paper will critically explore conceptualisations of responsibility, care and vulnerability in relation to contemporary approaches to Responsible Innovation (RI). Drawing on examples of some of the social and ethical challenges of precision medicine, we highlight the on-going, distributed and complex nature of innovation and responsibilities in relation to markets, patient and carer experience and data practices associated with these new technologies to highlight some of the limits of RI. We end by reflecting on the implications of our analysis for the social and ethical challenges of precision medicine and RI more generally.

LanguageEnglish
Pages24-31
Number of pages8
JournalTechnology in Society
Volume52
DOIs
Publication statusPublished - 1 Feb 2018
Externally publishedYes

Fingerprint

Medicine
vulnerability
Innovation
medicine
innovation
responsibility
technology studies
science studies
new technology
Vulnerability
market
experience
Responsibility

Cite this

@article{a8a529dfd6e84905b2d650d3d8812724,
title = "The limits of responsible innovation: Exploring care, vulnerability and precision medicine",
abstract = "Drawing on insights from feminist and Science and Technology Studies writing on care and vulnerability, this paper will critically explore conceptualisations of responsibility, care and vulnerability in relation to contemporary approaches to Responsible Innovation (RI). Drawing on examples of some of the social and ethical challenges of precision medicine, we highlight the on-going, distributed and complex nature of innovation and responsibilities in relation to markets, patient and carer experience and data practices associated with these new technologies to highlight some of the limits of RI. We end by reflecting on the implications of our analysis for the social and ethical challenges of precision medicine and RI more generally.",
keywords = "health data",
author = "Anne Kerr and Hill, {Rosemary Lucy} and Christopher Till",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.techsoc.2017.03.004",
language = "English",
volume = "52",
pages = "24--31",
journal = "Technology in Society",
issn = "0160-791X",
publisher = "Elsevier Limited",

}

The limits of responsible innovation : Exploring care, vulnerability and precision medicine. / Kerr, Anne; Hill, Rosemary Lucy; Till, Christopher.

In: Technology in Society, Vol. 52, 01.02.2018, p. 24-31.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The limits of responsible innovation

T2 - Technology in Society

AU - Kerr, Anne

AU - Hill, Rosemary Lucy

AU - Till, Christopher

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Drawing on insights from feminist and Science and Technology Studies writing on care and vulnerability, this paper will critically explore conceptualisations of responsibility, care and vulnerability in relation to contemporary approaches to Responsible Innovation (RI). Drawing on examples of some of the social and ethical challenges of precision medicine, we highlight the on-going, distributed and complex nature of innovation and responsibilities in relation to markets, patient and carer experience and data practices associated with these new technologies to highlight some of the limits of RI. We end by reflecting on the implications of our analysis for the social and ethical challenges of precision medicine and RI more generally.

AB - Drawing on insights from feminist and Science and Technology Studies writing on care and vulnerability, this paper will critically explore conceptualisations of responsibility, care and vulnerability in relation to contemporary approaches to Responsible Innovation (RI). Drawing on examples of some of the social and ethical challenges of precision medicine, we highlight the on-going, distributed and complex nature of innovation and responsibilities in relation to markets, patient and carer experience and data practices associated with these new technologies to highlight some of the limits of RI. We end by reflecting on the implications of our analysis for the social and ethical challenges of precision medicine and RI more generally.

KW - health data

UR - http://www.scopus.com/inward/record.url?scp=85015723095&partnerID=8YFLogxK

U2 - 10.1016/j.techsoc.2017.03.004

DO - 10.1016/j.techsoc.2017.03.004

M3 - Article

VL - 52

SP - 24

EP - 31

JO - Technology in Society

JF - Technology in Society

SN - 0160-791X

ER -